Fig. 5

Overall investigators appreciation of product efficacy during the study. Qualitative evaluation of clinical improvement was rated as “poor”, “good”, “very good” or “excellent” on D0 + 15 days and on D0 + 30 days by the investigators
Overall investigators appreciation of product efficacy during the study. Qualitative evaluation of clinical improvement was rated as “poor”, “good”, “very good” or “excellent” on D0 + 15 days and on D0 + 30 days by the investigators